Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain 3 Neuralgia 3 Breast Neoplasms 3 Seizures 1 Pinealoma 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Myotoxicity 1 Meningioma 1 Medulloblastoma 1 Lymphoma 1 Inflammation 1 Head and Neck Neoplasms 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 Ependymoma 1 Earache 1 Drug-Related Side Effects and Adverse Reactions 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Agnosia 1

Interventions

Cisplatin 131 Cetuximab 80 Radiotherapy 76 Docetaxel 59 Carboplatin 46 pembrolizumab 45 Paclitaxel 44 Fluorouracil 42 Radiotherapy, Intensity-Modulated 35 Drug Therapy 17 Radiation 14 Nivolumab 14 Gefitinib 14 Gemcitabine 13 Surgical Procedures, Operative 12 Oxaliplatin 11 Erlotinib Hydrochloride 11 130-nm albumin-bound paclitaxel 11 Pemetrexed 10 Celecoxib 10 Capecitabine 10 Bevacizumab 10 tislelizumab 9 Filgrastim 9 Amifostine 9 Albumin-Bound Paclitaxel 9 durvalumab 7 atezolizumab 7 Chemoradiotherapy 7 toripalimab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Head and Neck Neoplasms × Pregabalin × Clear all

NCT06766916 2025-05-18

CRYSTAL

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 2 Recruiting

Head and Neck Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡